Henrik Frystyk Nielsen - Infectious Diseases

Author Information

Henrik Frystyk Nielsen is affiliated with the Department of Infectious Diseases at Aalborg University Hospital in Aalborg, Denmark. He is a prominent figure in the field of infectious diseases, contributing significantly to research and understanding of various infectious conditions, including meningitis and COVID-19. His work has been influential in both clinical and epidemiological contexts, providing insights into disease management and outcomes.

Research Contributions

Henrik Frystyk Nielsen has authored several pivotal studies, with a particular focus on meningitis and the COVID-19 pandemic. Some of his notable works include a nationwide study on Herpes simplex virus 2 meningitis in adults and research on the treatment of COVID-19 patients with remdesivir and dexamethasone. He has also explored the implications of delayed antibiotic treatment in bacterial meningitis and evaluated the healthcare system's response to non-COVID conditions during the pandemic. His research has had significant impact on clinical practices and policy-making.

Aliases

Throughout his academic career, Henrik Frystyk Nielsen has been referenced under several aliases, including H Nielsen, H. Nielsen, and Henrik Nielsen. These variations are likely due to differences in citation practices across publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	1430
H-index	23
Paper Count	103

Publications:

Herpes simplex virus 2 meningitis in adults: A prospective, nationwide, population-based cohort study.

DOI: 10.1093/cid/ciab1071

Year: 2022

Positive Predictive Value of the ICD-10 Diagnosis Code for Long-COVID

DOI: 10.2147/CLEP.S344515

Year: 2022

Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort

DOI: 10.1038/s41598-021-04349-7

Year: 2022

Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.

DOI: 10.1093/cid/ciac243

Year: 2022

Reply To Author.

DOI: 10.1093/cid/ciab165

Year: 2021

Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study

DOI: 10.1136/bmj.n1135

Year: 2021

Enterovirus Meningitis in Adults

DOI: 10.1212/WNL.0000000000012294

Year: 2021

First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

DOI: 10.1186/s12879-020-05717-w

Year: 2021

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: the COVID STEROID randomised, placebo‐controlled trial

DOI: 10.1111/aas.13941

Year: 2021

Existing Data Sources for Clinical Epidemiology: The Danish Study Group of Infections of the Brain Database (DASGIB)

DOI: 10.2147/CLEP.S326461

Year: 2021

What is Plasmodium falciparum?

What are the Complications Associated with Zika Virus?

How do emerging infectious diseases pose a threat?

How Does a PCR Test Work?

Can E. Coli Infections Lead to Long-Term Complications?

What Are the Treatment Options for Infected Newborns?

How Are Blood Tests Conducted?

How to Combat Antimicrobial Resistance?

What Role Does Community Engagement Play?

What is HIV?

Partnered Content Networks

Relevant Topics